Onglyza

Product manufactured by Cardinal Health

Application Nr Approved Date Route Status External Links
NDA022350 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Onglyza Is A Dipeptidyl Peptidase-4 (Dpp4) Inhibitor Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. ( 1.1 , 14 ) Limitation Of Use: • Not Used For The Treatment Of Type 1 Diabetes Mellitus Or Diabetic Ketoacidosis. ( 1.2 ) 1.1 Monotherapy And Combination Therapy Onglyza Is Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus [ See Clinical Studies (14) ]. 1.2 Limitations Of Use Onglyza Is Not Indicated For The Treatment Of Type 1 Diabetes Mellitus Or Diabetic Ketoacidosis, As It Would Not Be Effective In These Settings.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Saxagliptin Hydrochloride SAXAGLIPTIN HYDROCHLORIDE ZINC100037885

Comments